Shanghai Junshi Biosciences Co., Ltd.
SHJBF
Get informed when a big investor buys or sells
+ FollowMarket Cap$34.45B
Close$
Share Statistics
| Market cap | $34.45 Billion |
|---|---|
| Enterprise Value | $37.69 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.84 |
| Beta | 0.58 |
| Outstanding Shares | 1,025,874,000 |
Return
| Return on Equity | -7.42% |
|---|---|
| Return on Assets | -3.09% |
| Return on Invested Capital | -5.51% |
Valuation & Multiples
| P/E Ratio | -78.89 |
|---|---|
| PEG | 63.75 |
| Price to Sales | 1.68 |
| Price to Book Ratio | 0.56 |
| Enterprise Value to Revenue | 12.46 |
| Enterprise Value to EBIT | -60.14 |
| Enterprise Value to Net Income | -86 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 1.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 30, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Shanghai Junshi Biosciences Co., Ltd.
3,055 employees
CEO: Cong Li Shanghai Junshi Biosciences Co., Ltd. is a biopharmaceutical firm focused on the research, creation, and marketing of diverse pharmaceutical products. Operating within the People's Republic of China, its therapeutic focus spans oncology,...